van Lieshout E M, Bedaf M M, Pieter M, Ekkel C, Nijhoff W A, Peters W H
Department of Gastroenterology, St Radboud University Hospital, Nijmegen, The Netherlands.
Carcinogenesis. 1998 Nov;19(11):2055-7. doi: 10.1093/carcin/19.11.2055.
Several naturally occurring food components or non-steroidal anti-inflammatory drugs (NSAIDs) may reduce gastrointestinal cancer rates. Recently we have shown that dietary administration of such compounds enhanced the glutathione S-transferase (GST) enzyme activity and class alpha, mu and pi isoenzyme levels in the rat gastrointestinal tract. Elevation of the levels of GSTs, a family of biotransformation enzymes with many functions such as detoxification of carcinogens, might be one of the mechanisms that lead to cancer prevention. We therefore investigated whether the anticarcinogens alpha-angelicalactone, alpha-tocopherol, beta-carotene, coumarin, ellagic acid, flavone, indole-3-carbinol, d-limonene, oltipraz, phenethylisothiocyanate (PEITC) and the sulphoraphane analogue compound-30 affect gastrointestinal rGSTT1-1 protein levels in male Wistar rats. rGSTT1-1 protein levels were determined in cytosolic fractions of liver and oesophageal-, gastric-, small intestinal- and colonic mucosa by densitometrical analyses of western blots after immunodetection with an anti human GSTT1-1 monoclonal antibody, that cross-reacts with rGSTT1-1. In control Wistar rats, gastrointestinal rGSTT1-1 protein levels were highest in the liver and decreased in the order liver > stomach > colon > oesophagus > small intestine. Gastric rGSTT1-1 protein levels were enhanced by alpha-angelicalactone, alpha-tocopherol, coumarin, ellagic acid, oltipraz, PEITC and the sulphoraphane analogue compound-30. Oesophageal rGSTT1-1 protein levels were elevated by a-angelicalactone and coumarin, whereas colonic rGSTT1-1 protein levels were elevated by coumarin. Ellagic acid, on the other hand, reduced hepatic rGSTT1-1 protein levels to 53% of the control. In conclusion, dietary anticarcinogens are capable of inducing rGSTT1-1 protein levels in the rat gastrointestinal tract, and are most pronounced in the stomach. Enhanced rGSTT1-1 protein levels might lead to an increase of enzyme activity and to a more efficient detoxification of carcinogens and thus could contribute to prevention of carcinogenesis.
几种天然存在的食物成分或非甾体抗炎药(NSAIDs)可能会降低胃肠道癌症的发病率。最近我们发现,给大鼠喂食这类化合物可增强其胃肠道中谷胱甘肽S-转移酶(GST)的酶活性以及α、μ和π类同工酶的水平。GSTs是一类具有多种功能(如致癌物解毒)的生物转化酶,其水平的升高可能是预防癌症的机制之一。因此,我们研究了抗癌剂α-当归内酯、α-生育酚、β-胡萝卜素、香豆素、鞣花酸、黄酮、吲哚-3-甲醇、d-柠檬烯、奥替普拉、苯乙基异硫氰酸酯(PEITC)和萝卜硫素类似物化合物-30是否会影响雄性Wistar大鼠胃肠道中rGSTT1-1蛋白的水平。在用与人GSTT1-1单克隆抗体发生交叉反应的抗rGSTT1-1抗体进行免疫检测后,通过对蛋白质印迹进行光密度分析,测定肝脏以及食管、胃、小肠和结肠黏膜胞质部分的rGSTT1-1蛋白水平。在对照Wistar大鼠中,胃肠道rGSTT1-1蛋白水平在肝脏中最高,且按肝脏>胃>结肠>食管>小肠的顺序降低。α-当归内酯、α-生育酚、香豆素、鞣花酸、奥替普拉、PEITC和萝卜硫素类似物化合物-30可提高胃rGSTT1-1蛋白水平。α-当归内酯和香豆素可提高食管rGSTT1-1蛋白水平,而香豆素可提高结肠rGSTT1-1蛋白水平。另一方面,鞣花酸可将肝脏rGSTT1-1蛋白水平降至对照水平的53%。总之,饮食中的抗癌剂能够诱导大鼠胃肠道中rGSTT1-1蛋白水平升高,且在胃中最为明显。rGSTT1-1蛋白水平的提高可能会导致酶活性增加以及致癌物解毒更有效,从而有助于预防癌变。